← Back to Search

Dietary Supplement

Carbohydrates intake for Patient Adherence

N/A
Waitlist Available
Led By Rajavel Elango, PhD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 hours
Awards & highlights

Study Summary

This trial will examine how well different carbohydrates are digested by people with GSD I and healthy controls.

Eligible Conditions
  • Patient Adherence
  • Healthy Subjects

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Glucose oxidation

Trial Design

2Treatment groups
Experimental Treatment
Group I: Glucose intakeExperimental Treatment1 Intervention
Experiment 1: study day 1- single oral dose of glucose study day 2- single oral dose of glucose with U-13C-glucose
Group II: Carbohydrates intakeExperimental Treatment1 Intervention
Experiment 2: study day 1-single oral dose of uncooked cornstarch study day 2-single oral dose of uncooked cornstarch with U-13C-glucose study day 3-single oral dose of Glycosade® study day 4-single oral dose of Glycosade® with U-13C-glucose
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Glucose intake
2016
N/A
~40

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,415 Previous Clinical Trials
2,466,978 Total Patients Enrolled
Saudi Arabian Cultural Bureau, OttawaUNKNOWN
1 Previous Clinical Trials
4 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,344 Previous Clinical Trials
26,453,379 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Apr 2025